Charles Jiang MD, MPH(@CharlesJiangMD) 's Twitter Profileg
Charles Jiang MD, MPH

@CharlesJiangMD

Changchuan(Charles) Jiang MD MPH
GU Med Onc, UTSW Ass Prof
Interested in patient-centered cancer care /survivor/service/outcome research/GU med onc

ID:1157347705322188800

calendar_today02-08-2019 17:49:30

439 Tweets

754 Followers

661 Following

Ashok Rai, M.D. (he/him)(@preveaceo) 's Twitter Profile Photo

The American Cancer Society is funding life-saving cancer research. This October, @Chevrolet is helping our friends @americancancer raise money to support these critical research efforts - through Oct. 31, for every tweet/RT using , Chevy will donate $5. Retweet this!

account_circle
Charles Jiang MD, MPH(@CharlesJiangMD) 's Twitter Profile Photo

Incredibly useful concept to expand access and the cooler part is no AE or SAE diff between IO and control arm. Does it make sense to test this 10% ultralow dose in pt with high risk irAE(hx of autoimmune disease)?

account_circle
Charles Jiang MD, MPH(@CharlesJiangMD) 's Twitter Profile Photo

Just had an incredible ' mock interview' session with the famous and honest H. Jack West, MD. So much excellent advice for junior investigators!

account_circle
Nicholas Zaorsky, MD MS(@NicholasZaorsky) 's Twitter Profile Photo

If I had to rank possible research project endeavors for medical students + residents, here is how I would evaluate them:

I would consider pursuing # 1-3.

The mentor is the most important part of the puzzle and can spark interest in a topic.

If I had to rank possible research project endeavors for medical students + residents, here is how I would evaluate them: I would consider pursuing # 1-3. The mentor is the most important part of the puzzle and can spark interest in a topic. #MedTwitter #AcademicTwitter
account_circle
The ASCO Post(@ASCOPost) 's Twitter Profile Photo

Changchuan Jiang, MD, MPH, on Transportation Barriers, Delays in Cancer Care, and Increased Mortality for Patients With Cancer ascopost.com/videos/2022-as… Changchuan(Charles) Jiang MD, MPH Roswell Park

account_circle
Ashwin Kishtagari, MD(@AshKishtagari) 's Twitter Profile Photo

Therapy-related myeloid neoplasms following PARP inhibitors: real-life experience Clinical Cancer Research

👉Cumulative incidence of t-MN was 3.5% (13/373) among ovarian cancer patients treated with PARPi. (1/2)

aacrjournals.org/clincancerres/…

account_circle
Dr. Monica M. Bertagnolli(@NCIDirector) 's Twitter Profile Photo

Put simply, I hate cancer.

The pain of lost patients and devastated families drives me to improve how we develop interventions and deliver for all. We must challenge conventional thinking and remove arbitrary restrictions.

account_circle